CLOS
PFE icon

Compagnie Lombard Odier SCmA’s Pfizer PFE Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-6,000
Closed -$14K – 666
2021
Q4 		$14K Buy
+6,000
New +$297K ﹤0.01% 608

Other funds holding PFE

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Compagnie Lombard Odier SCmA's PFE Position: Q2 2026 in Review

Compagnie Lombard Odier SCmA increased its Pfizer (PFE) stake by 0.42% in Q2 2026, buying an estimated $41.5K and bringing the position to 382,649 shares worth $9.21M. The position accounts for 0.1% of the portfolio, ranked #104.

Compagnie Lombard Odier SCmA first reported a position in PFE in Q4 2013 and has held it in 51 quarters since. The position peaked at $18.8M in Q4 2015. 1,210 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Compagnie Lombard Odier SCmA held 382,649 shares of Pfizer worth $9.21M as of Q2 2026.
  • Compagnie Lombard Odier SCmA bought 1,588 Pfizer shares in Q2 2026, an estimated $41.5K.
  • Pfizer made up 0.1% of Compagnie Lombard Odier SCmA's portfolio in Q2 2026, its #104 holding.
  • Compagnie Lombard Odier SCmA first reported a position in Pfizer in Q4 2013 and has held it in 51 quarters since.
  • Compagnie Lombard Odier SCmA's Pfizer position peaked at $18.8M in Q4 2015.
  • 1,210 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2026, filed 29 Jul 2026.